Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Cronos Has Too Many Red Flags That Should Scare Investors Away

By Chris Lau, InvestorPlace Contributor

Cronos lacks any positive catalysts ahead, other than holding Altria’s billions of cash in investments

Exxon Stock Will Reward You If You Can Time the Cycle Right

By Chris Lau, InvestorPlace Contributor

XOM stock needs a jolt in the form of higher oil prices driven by stronger demand, before the cycle turns upward.

7 Companies to Invest In Ahead of Q4 for Long-term Returns

By Chris Lau, InvestorPlace Contributor

Volatility is worsening ahead of the U.S. elections, so here are 7 companies to invest in rather than getting discouraged.

Snowflake Due to Settle Down Any Day Now

By Chris Lau, InvestorPlace Contributor

Snowflake is bound to expand its addressable market through to 2023 and investors are willing to pay too much for it.

Make Your Play Soon, Because Lockheed Martin Stock Is on the Verge of a Breakout

By Chris Lau, InvestorPlace Contributor

LMT Stock is in value territory after the company raised dividends and increased the stock buyback.

Load More